Correlation Between Mineralys Therapeutics, and Senti Biosciences
Can any of the company-specific risk be diversified away by investing in both Mineralys Therapeutics, and Senti Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mineralys Therapeutics, and Senti Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mineralys Therapeutics, Common and Senti Biosciences, you can compare the effects of market volatilities on Mineralys Therapeutics, and Senti Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mineralys Therapeutics, with a short position of Senti Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mineralys Therapeutics, and Senti Biosciences.
Diversification Opportunities for Mineralys Therapeutics, and Senti Biosciences
-0.63 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Mineralys and Senti is -0.63. Overlapping area represents the amount of risk that can be diversified away by holding Mineralys Therapeutics, Common and Senti Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Senti Biosciences and Mineralys Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mineralys Therapeutics, Common are associated (or correlated) with Senti Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Senti Biosciences has no effect on the direction of Mineralys Therapeutics, i.e., Mineralys Therapeutics, and Senti Biosciences go up and down completely randomly.
Pair Corralation between Mineralys Therapeutics, and Senti Biosciences
Given the investment horizon of 90 days Mineralys Therapeutics, Common is expected to under-perform the Senti Biosciences. In addition to that, Mineralys Therapeutics, is 1.67 times more volatile than Senti Biosciences. It trades about -0.03 of its total potential returns per unit of risk. Senti Biosciences is currently generating about -0.03 per unit of volatility. If you would invest 222.00 in Senti Biosciences on August 30, 2024 and sell it today you would lose (8.00) from holding Senti Biosciences or give up 3.6% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Mineralys Therapeutics, Common vs. Senti Biosciences
Performance |
| Timeline |
| Mineralys Therapeutics, |
| Senti Biosciences |
Mineralys Therapeutics, and Senti Biosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Mineralys Therapeutics, and Senti Biosciences
The main advantage of trading using opposite Mineralys Therapeutics, and Senti Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mineralys Therapeutics, position performs unexpectedly, Senti Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Senti Biosciences will offset losses from the drop in Senti Biosciences' long position.| Mineralys Therapeutics, vs. Evolution Gaming Group | Mineralys Therapeutics, vs. Mativ Holdings | Mineralys Therapeutics, vs. CF Industries Holdings | Mineralys Therapeutics, vs. The Mosaic |
| Senti Biosciences vs. Cadrenal Therapeutics, Common | Senti Biosciences vs. Foghorn Therapeutics | Senti Biosciences vs. Quoin Pharmaceuticals Ltd | Senti Biosciences vs. SAB Biotherapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Other Complementary Tools
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |